Ascierto PA, Dreno B, Larkin J, Ribas A, et al. 5-Year Outcomes with Cobimetinib Plus Vemurafenib in BRAF (V600) Mutation-Positive Advanced Melanoma: Extended Follow-Up of the coBRIM Study. Clin Cancer Res 2021 Jun 22. pii: 1078-0432.CCR-21-0809.
PMID: 34158360